×
About 2,938 results

ALLMedicine™ Tardive Dyskinesia Center

Research & Reviews  1,143 results

Patient perspective of tardive dyskinesia: results from a social media listening study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885234
BMC Psychiatry; Farrar M, Lundt L et. al.

Feb 16th, 2021 - Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with prolonged exposure to dopamine receptor blocking agents such as antipsychotics. With the expanding use of antipsychotics, research is needed to bet...

Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsych...
https://doi.org/10.1097/JCP.0000000000001352
Journal of Clinical Psychopharmacology; Khurram SK, Ames M et. al.

Feb 15th, 2021 - Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.|2021|Khurram SK,Ames M,Muniz J,|

Recent discussions on dopamine supersensitivity psychosis: Eight points to consider whe...
https://doi.org/10.2174/1570159X19666210125152815
Current Neuropharmacology; Kanahara N, Kimura H et. al.

Feb 8th, 2021 - Dopamine supersensitivity psychosis is a clinical concept characterized by an unstable psychotic state and tardive dyskinesia in schizophrenia patients at the chronic stage. This state is thought to be induced by a compensatory upregulation of dop...

Naringin Ameliorates Haloperidol-Induced Neurotoxicity and Orofacial Dyskinesia in a Ra...
https://doi.org/10.1007/s12640-021-00333-1 10.1016/j.fct.2019.110646 10.3390/nu5030637 10.1016/j.cbi.2015.12.011 10.1016/S0021-9258(19)50881-X 10.1016/j.biopha.2018.10.055 10.1055/s-0034-1368351 10.1016/j.neuroscience.2007.04.002 10.1007/978-1-61779-458-2_12 10.1016/j.ejphar.2008.06.033 10.1016/j.pbb.2007.10.009 10.1007/s11064-008-9660-6 10.1016/j.pbb.2008.08.021 10.1016/j.pbb.2005.05.002 10.1038/nrn2214 10.4077/CJP.2018.BAG529 10.1080/13880209.2016.1216131 10.1016/j.pnpbp.2012.10.018 10.1097/00005344-200112000-00017 10.4088/JCP.tv17016ah4c 10.1016/j.fct.2018.08.028 10.1016/j.ejphar.2015.12.032 10.1080/1028415X.2017.1338549 10.1016/0003-9861(59)90090-6 10.1016/j.lfs.2020.117535 10.1016/j.yebeh.2014.09.058 10.1093/jn/135.3.549 10.1002/ptr.3724 10.3109/08923973.2011.564186 10.1016/j.yebeh.2017.07.011 10.1016/S0021-9258(19)52451-6 10.1016/S0021-9258(19)45228-9 10.1016/0003-2697(79)90738-3 10.1016/j.diabres.2012.02.011 10.1016/j.jchromb.2005.01.008 10.1016/j.abb.2011.11.026 10.1016/j.biopha.2016.10.080 10.2174/13895575113136660100 10.1016/j.pbb.2014.11.002 10.1159/000453580 10.1007/s12640-018-9897-z 10.1007/s40263-018-0494-8 10.4103/CJP.CJP_8_19 10.1016/j.biopha.2017.07.072 10.3390/ijms14035576 10.1142/S0192415X07005156 10.3389/fphar.2019.00034
Neurotoxicity Research; Wang MH, Yang CC et. al.

Feb 1st, 2021 - Animal models of haloperidol (HAL)-induced neurotoxicity and orofacial dyskinesia (OD) have long been used to study human tardive dyskinesia (TD). Similar to patients with TD, these models show strong pathophysiological characteristics such as str...

Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747756
Tremor and Other Hyperkinetic Movements (New York, N.Y.); Sharma VD, Gupta HV et. al.

Dec 28th, 2020 - Copulatory or pelvic thrusting dyskinesia is a subtype of tardive dyskinesia (TD) which is caused by exposure to dopamine blocking agents. A man exhibiting rhythmic, stereotypical pelvic thrusting movements. Recognition of copulatory dyskinesia as...

see more →

Guidelines  1 results

Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskin...
https://doi.org/10.4088/JCP.17cs11959
The Journal of Clinical Psychiatry; Kane JM, Correll CU et. al.

May 9th, 2018 - To provide an historic overview of the Abnormal Involuntary Movement Scale (AIMS) in clinical trials of tardive dyskinesia (TD), with current recommendations for analyzing and interpreting AIMS data. Seven psychiatrists and 1 neurologist were sele...

see more →

Drugs  177 results see all →

Clinicaltrials.gov  1,433 results

Patient perspective of tardive dyskinesia: results from a social media listening study.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885234
BMC Psychiatry; Farrar M, Lundt L et. al.

Feb 16th, 2021 - Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with prolonged exposure to dopamine receptor blocking agents such as antipsychotics. With the expanding use of antipsychotics, research is needed to bet...

Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsych...
https://doi.org/10.1097/JCP.0000000000001352
Journal of Clinical Psychopharmacology; Khurram SK, Ames M et. al.

Feb 15th, 2021 - Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.|2021|Khurram SK,Ames M,Muniz J,|

Metoclopramide - metoclopramide tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=264c4f48-51f4-458f-9e61-1adafdf604fc

Feb 14th, 2021 - Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. Relief of symptoms in adults with acute and recurrent diabetic gast...

Recent discussions on dopamine supersensitivity psychosis: Eight points to consider whe...
https://doi.org/10.2174/1570159X19666210125152815
Current Neuropharmacology; Kanahara N, Kimura H et. al.

Feb 8th, 2021 - Dopamine supersensitivity psychosis is a clinical concept characterized by an unstable psychotic state and tardive dyskinesia in schizophrenia patients at the chronic stage. This state is thought to be induced by a compensatory upregulation of dop...

Naringin Ameliorates Haloperidol-Induced Neurotoxicity and Orofacial Dyskinesia in a Ra...
https://doi.org/10.1007/s12640-021-00333-1 10.1016/j.fct.2019.110646 10.3390/nu5030637 10.1016/j.cbi.2015.12.011 10.1016/S0021-9258(19)50881-X 10.1016/j.biopha.2018.10.055 10.1055/s-0034-1368351 10.1016/j.neuroscience.2007.04.002 10.1007/978-1-61779-458-2_12 10.1016/j.ejphar.2008.06.033 10.1016/j.pbb.2007.10.009 10.1007/s11064-008-9660-6 10.1016/j.pbb.2008.08.021 10.1016/j.pbb.2005.05.002 10.1038/nrn2214 10.4077/CJP.2018.BAG529 10.1080/13880209.2016.1216131 10.1016/j.pnpbp.2012.10.018 10.1097/00005344-200112000-00017 10.4088/JCP.tv17016ah4c 10.1016/j.fct.2018.08.028 10.1016/j.ejphar.2015.12.032 10.1080/1028415X.2017.1338549 10.1016/0003-9861(59)90090-6 10.1016/j.lfs.2020.117535 10.1016/j.yebeh.2014.09.058 10.1093/jn/135.3.549 10.1002/ptr.3724 10.3109/08923973.2011.564186 10.1016/j.yebeh.2017.07.011 10.1016/S0021-9258(19)52451-6 10.1016/S0021-9258(19)45228-9 10.1016/0003-2697(79)90738-3 10.1016/j.diabres.2012.02.011 10.1016/j.jchromb.2005.01.008 10.1016/j.abb.2011.11.026 10.1016/j.biopha.2016.10.080 10.2174/13895575113136660100 10.1016/j.pbb.2014.11.002 10.1159/000453580 10.1007/s12640-018-9897-z 10.1007/s40263-018-0494-8 10.4103/CJP.CJP_8_19 10.1016/j.biopha.2017.07.072 10.3390/ijms14035576 10.1142/S0192415X07005156 10.3389/fphar.2019.00034
Neurotoxicity Research; Wang MH, Yang CC et. al.

Feb 1st, 2021 - Animal models of haloperidol (HAL)-induced neurotoxicity and orofacial dyskinesia (OD) have long been used to study human tardive dyskinesia (TD). Similar to patients with TD, these models show strong pathophysiological characteristics such as str...

see more →

News  161 results

Fast Five Quiz: Schizophrenia Management in Adults
https://reference.medscape.com/viewarticle/933512_6

Aug 10th, 2020 - First-generation antipsychotics have a high rate of extrapyramidal side effects, including rigidity, bradykinesia, dystonias, tremor, and akathisia. Tardive dyskinesia —involuntary movements of the face and extremities — is another adverse effect ...

The ABCDs of treating tardive dyskinesia
https://www.mdedge.com/psychiatry/article/219775/schizophrenia-other-psychotic-disorders/abcds-treating-tardive-dyskinesia?channel=133
Jonathan R. Scarff, MD

Mar 31st, 2020 - Tardive dyskinesia (TD)—involuntary movement persisting for >1 month—is often caused by exposure to dopamine receptor–blocking agents such as antipsychotics. 1 The pathophysiology of TD is attributed to dopamine receptor hypersensitivity and upregu.

A 39-Year-Old Woman With Past Cocaine Use, Rash, and Seizure
https://reference.medscape.com/viewarticle/898695_4

Mar 12th, 2020 - Reports have documented reversal of tardive dyskinesia with steroids. Oxidative stress as an inducer of Tardive dyskinesia has also been implicated.[7] Thus, more research on tardive dyskinesia is indicated to better understand these phenomena. In...

Fast Five Quiz: Tardive Dyskinesia Differential Diagnosis
https://reference.medscape.com/viewarticle/923959_1

Feb 20th, 2020 - Tardive dyskinesia (TD) is a troubling side effect that may occur with long-term dopaminergic antagonist medications. TD manifests as involuntary movements of the tongue, lips, face, trunk, and extremities. It is most commonly seen in patients wit...

Fast Five Quiz: Tardive Dyskinesia Differential Diagnosis
https://reference.medscape.com/viewarticle/923959_2

Feb 20th, 2020 - Tardive tremors are rhythmic (as opposed to irregular tardive dyskinesia movements) and usually present at rest and with voluntary movement. This is distinct from cerebellar tremors, which are present with voluntary motion but not at rest. Additio...

see more →

Patient Education  23 results see all →